(Q34721804)

English

Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

author name string

Haria M

1

1 reference

Europe PubMed Central

4 August 2017

Bryson HM

2

1 reference

Europe PubMed Central

4 August 2017

publication date

1 January 1995

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

49

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

103-120

1 reference

Europe PubMed Central

4 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199549010-00008

0 references

Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of amorolfine on the morphology of Candida albicans and Trichophyton mentagrophytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption of amorolfine through human nail

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of amorolfine (Ro 14-4767/002) on in vitro phagocytosis and intracellular killing of Candida albicans by human neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of itraconazole in the management of onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tioconazole nail solution--an open study of its efficacy in onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal a

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal activity of four antifungal drugs in the cutaneous retention time test.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of amorolfine in human nails.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal susceptibility tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oxiconazole and Ro 14-4767/002 on sterol pattern in Candida albicans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The topical treatment of onychomycosis using a new combined urea/imidazole preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro studies with R 51,211 (itraconazole)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical and mycological studies of griseofulvin treated onychomycoses].

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amorolfine spray in the treatment of foot mycoses (a dose-finding study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of amorolfine with various antifungal drugs in dermatophytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of adherence of Candida albicans by conventional and experimental antifungal drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of temperature on anti-Candida activities of antifungal antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Onychomycosis. Agents of choice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[In vitro action spectrum of a new antifungal agent derived from morpholine: amorolfin]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of amorolfine and oxiconazole on the ultrastructure of Trichophyton mentagrophytes. A comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Dermatomycoses with Topical Tioconazole and Miconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal activity in vitro of Ro 14-4767/002, a phenylpropyl-morpholine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short term treatment of dermatophyte onychomycosis with terbinafine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphological changes associated with growth inhibition of Trichophyton mentagrophytes by amorolfine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of antifungal agents on germ tube formation in Candida albicans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical data and mode of action of amorolfine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose treatment of vaginal candidosis: randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bifonazole cream: once-a-day application every second day in tinea cruris and tinea corporis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the newer antifungal agents (bifonazole, ICI 195, 739 and amorolfin) on in vitro phagocytic, lymphocytic and natural-killer cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The unexpectedly rapid response of fungal nail infection to short duration therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bifonazole in the treatment of fungal skin infections in the tropics: a clinical and mycological study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amorolfine, a breakthrough in topical antimycotic therapy. Introduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of dermatomycoses and onychomycoses--state of the art

1 reference

https://pubmed.ncbi.nlm.nih.gov/7705210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199549010-00008

1 reference

Europe PubMed Central

4 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34721804&oldid=1634654804"